Noriyuki Enomoto Selected Research

Idiopathic Interstitial Pneumonias

1/2021	Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
11/2020	Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias.
7/2019	Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
1/2018	Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
5/2008	Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia.
1/2006	[Two cases of acute respiratory failure due to idiopathic interstitial pneumonia successfully treated with sivelestat sodium hydrate and steroid therapy].
11/2004	[A case of subacute idiopathic interstitial pneumonia resistant to steroids, successfully treated with cyclophosphamide].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriyuki Enomoto Research Topics

Disease

27	Idiopathic Pulmonary Fibrosis 01/2022 - 07/2005
21	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2004
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 12/2015
12	Neoplasms (Cancer) 02/2022 - 09/2017
11	Asthma (Bronchial Asthma) 05/2022 - 03/2003
11	Disease Progression 01/2022 - 01/2015
9	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 01/2015
8	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
8	Inflammation (Inflammations) 01/2022 - 02/2012
8	Infections 02/2021 - 01/2005
8	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2015
8	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 02/2005
7	Idiopathic Interstitial Pneumonias 01/2021 - 11/2004
6	Adenocarcinoma of Lung 01/2022 - 01/2017
6	Pneumonia (Pneumonitis) 02/2020 - 04/2004
5	Fibrosis (Cirrhosis) 01/2021 - 07/2005
5	Nausea 01/2019 - 12/2015
5	Vascular Diseases (Vascular Disease) 01/2016 - 11/2004
4	Sarcoidosis (Schaumann Disease) 11/2019 - 01/2005
4	Dyspnea (Shortness of Breath) 01/2019 - 11/2004
4	Vomiting 01/2019 - 12/2015
3	Death (Near-Death Experience) 04/2022 - 11/2020
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 10/2010
3	Pneumothorax 01/2021 - 01/2020
3	Rheumatoid Arthritis 07/2019 - 09/2008
3	Bronchiectasis 01/2018 - 11/2004
3	Cough 04/2016 - 12/2006
2	Body Weight (Weight, Body) 02/2022 - 12/2021
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022 - 06/2015
2	Cryptogenic Organizing Pneumonia 01/2022 - 02/2005
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Obesity 01/2022 - 01/2019
2	Neutropenia 01/2021 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2016
2	Myositis (Idiopathic Inflammatory Myopathies) 12/2016 - 01/2014
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 04/2016 - 12/2006
2	Granuloma 04/2016 - 01/2005
2	Hemorrhage 01/2016 - 07/2005

Drug/Important Bio-Agent (IBA)

11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 03/2003
8	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2015
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2014
7	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 07/2005
6	AutoantibodiesIBA 01/2022 - 01/2006
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 04/2012
6	CollagenIBA 01/2016 - 11/2004
5	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2015
4	NivolumabIBA 02/2022 - 01/2019
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2015
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2004
4	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2019
4	pirfenidoneIBA 07/2021 - 01/2014
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2017
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 01/2015
4	AntiemeticsIBA 01/2019 - 12/2015
4	AntibodiesIBA 12/2016 - 09/2008
4	Therapeutic UsesIBA 01/2015 - 05/2008
4	SteroidsIBA 01/2006 - 11/2004
3	Oxygen (Dioxygen)IBA 04/2022 - 03/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 11/2004
3	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 11/2004
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2013
3	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 11/2004
3	Interleukin-17 (Interleukin 17)IBA 10/2018 - 01/2014
3	CytokinesIBA 10/2018 - 02/2012
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	atezolizumabIBA 07/2022 - 01/2022
2	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
2	LigandsIBA 02/2022 - 01/2020
2	Serum AlbuminIBA 02/2022 - 12/2021
2	LipidsIBA 01/2022 - 01/2005
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2017
2	PlatinumIBA 12/2021 - 01/2021
2	Angiopoietin-1IBA 01/2021 - 01/2016
2	ImmunosorbentsIBA 01/2021 - 09/2008
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2015
2	EnzymesIBA 01/2021 - 09/2008
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2020 - 10/2010
2	Methylprednisolone FDA LinkGeneric 01/2020 - 07/2005
2	cyclic citrullinated peptideIBA 07/2019 - 09/2008
2	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 10/2016
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 10/2016
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 10/2016
2	Aprepitant (Emend)FDA Link 09/2018 - 12/2015
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 09/2018 - 07/2016
2	Pemetrexed (MTA)FDA Link 06/2018 - 05/2016
2	AntigensIBA 01/2018 - 01/2005
2	VaccinesIBA 11/2015 - 10/2009

Therapy/Procedure

41	Therapeutics 07/2022 - 03/2003
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2015
3	Artificial Respiration (Mechanical Ventilation) 04/2022 - 02/2005
2	Aftercare (After-Treatment) 01/2022 - 06/2015
2	Palliative Care (Palliative Therapy) 01/2021 - 11/2020